Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

MAB8694

Sigma-Aldrich

Anti-Hepatitis C Virus Antibody, NS5A

Chemicon®, from mouse

Synonym(s):

HCV

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

mouse

Quality Level

300

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable

isotype

IgG1

shipped in

wet ice

Specificity

Specific to HCV NS5A

Immunogen

Recombinant protein to NS5A

Application

ELISA

Immunofluorescence

RIA

Western Blot

Optimal working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
This Anti-Hepatitis C Virus Antibody, NS5A is validated for use in ELISA, IF, WB, IH for the detection of Hepatitis C Virus.

Physical form

Format: Purified
Liquid 0.02M PB, 0.25M NaCl, 0.1% sodium azide

Storage and Stability

Store at 2 to 8°C for up to 12 months from date of receipt.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Chang Ho Lee et al.
Molecular therapy. Nucleic acids, 4, e254-e254 (2015-10-07)
Hepatitis C virus (HCV) is the major cause of progressive liver disease such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Previously, we reported that a 29 nucleotide-long 2'-F pyrimidine modified RNA aptamer against the HCV nonstructural protein 5B efficiently inhibited
Azhar Mehmood et al.
Viral immunology, 30(8), 568-575 (2017-09-06)
Hepatitis C Virus (HCV) infection is a major health concern worldwide. The presence of both HCV viral RNA and NS5A proteins in peripheral blood mononuclear cells (PBMCs) indicate the efficacy of the treatment during sustained virological response (SVR) and end
Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Lee, CH; Lee, YJ; Kim, JH; Lim, JH; Kim, JH; Han, W; Lee, SH; Noh, GJ; Lee, SW
Journal of virology null
Hepatitis C virus replication-specific inhibition of microRNA activity with self-cleavable allosteric ribozyme.
Chang Ho Lee,Ji Hyun Kim,Hee Won Kim,Heejoon Myung,Seong-Wook Lee
Nucleic Acid Therapeutics null
Shao-Ru Chen et al.
Molecules (Basel, Switzerland), 21(10) (2016-10-19)
Hepatitis C virus (HCV) infects 200 million people worldwide, and 75% of HCV cases progress into chronic infections, which consequently cause cirrhosis and hepatocellular carcinoma. HCV infection is treated with currently considered standard drugs, including direct anti-viral agents (DAAs), alone
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service